Despite its entrenched position in the U.S. retail sector, this powerful discount chain still has the characteristics of a ...

Bernard emphasized strong performances in the QIAstat Diagnostics and QuantiFERON portfolios, with QIAstat achieving 25% CER growth in Q4 and over 660 new system placements in 2024. QuantiFERON grew ...

Read here for an analysis of FNY mid-cap growth fund, highlighting flaws in value screening but praising growth features.

Many startups are flying blind when trying to grow revenue. It’s understandable; most don’t ever go to college to learn how ...

For example, the membership-based retailer's ... The company reported January adjusted comparable sales growth rates for Canada, other international, and e-commerce of 12.3%, 10%, and 15.2% ...

Despite supportive earnings, DeepSeek shocked technology stocks. In the busiest week of the earnings season, tariffs and the ...

To meet its sales goals, Tesla will probably need a new model and significant advancements in autonomous driving.

Net sales of $521 million (+2% actual rates, +4% constant exchange rates (CER) core growth); diluted EPS of $0.39 and ...

Company highlights key milestones achieved in 2024, growing revenues and progress towards U.S. expansion in 2025. NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solut ...

The growth was attributed to the increase in military and commercial aftermarket sales. RTX’s Raytheon ... to requests for proposals. “For example, using generative AI, Collins’ avionics ...

US bakery major Flowers Foods has blamed ongoing bread category weakness and changing consumer preferences for ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions ...